Arthritis, Musculoskeletal and Skin Diseases Research in California
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $336 million to recipients in California in 347 grants from fiscal 2021 to 2025, 13% of the program's national total. The Regents of the University of California, San Francisco received the most, $93.3 million.
- Awarded in California$336 million
- Awards347
- Share of the program13%
- Rank among states1st of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 173 | $65.1 million |
| FY 2022 | 181 | $69.1 million |
| FY 2023 | 184 | $69.4 million |
| FY 2024 | 169 | $65.2 million |
| FY 2025 | 164 | $67.2 million |
Recipients in California
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | Colleges and universities | 84 | $93.3 million |
| The Leland Stanford Junior University | Colleges and universities | 57 | $56.8 million |
| University of California, Los Angeles | Colleges and universities | 37 | $43.7 million |
| University of California, San Diego | Colleges and universities | 33 | $31.3 million |
| University of California Irvine | Colleges and universities | 28 | $29.0 million |
| University of Southern California | Colleges and universities | 19 | $18.8 million |
| University of California, Davis | Colleges and universities | 25 | $16.4 million |
| Sanford Burnham Prebys Medical Discovery Institute | Nonprofits | 5 | $9.8 million |
| Cedars-Sinai Medical Center | Nonprofits | 7 | $7.4 million |
| Loma Linda Veterans Association for Research and Education | Nonprofits | 3 | $3.2 million |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to California?
$336 million from fiscal 2021 to 2025, across 347 awards. California ranks 1st of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in California?
The largest recipient is The Regents of the University of California, San Francisco, with $93.3 million in 84 awards. Next are The Leland Stanford Junior University and University of California, Los Angeles.
Can organizations in California apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in California
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Federal Transit Formula Grants
- Title I Grants to Local Educational Agencies
- Head Start